SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-083556
Filing Date
2015-12-08
Accepted
2015-12-08 12:36:52
Documents
6
Period of Report
2015-12-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-24697_18k.htm 8-K 28241
2 EX-99.1 a15-24697_1ex99d1.htm EX-99.1 37424
3 EX-99.2 a15-24697_1ex99d2.htm EX-99.2 9494
4 GRAPHIC g246971mmi001.jpg GRAPHIC 4271
5 GRAPHIC g246971mmi002.jpg GRAPHIC 4917
6 GRAPHIC g246971moi001.gif GRAPHIC 5928
  Complete submission text file 0001104659-15-083556.txt   97617
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 151274619
SIC: 2834 Pharmaceutical Preparations